RxDoctor Payments Data

Steven McMahan, MD

Family Medicine · West Monroe, LANPI 1497799456

Payments from drug & device makers

$10,909in general payments, 2019–2025

Across 605 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novo Nordisk$1K
  • Medtronic$1K
  • Lilly USA, LLC$904
  • AstraZeneca$864
  • AbbVie$846
  • plus $4K from 35 others

What the payments were for

  • Travel & lodging$7036%
  • Food & beverage$10,19493%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,909 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$169,506
Medicare patients
367
Services billed
3,039

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban104$114,774
JardianceEmpagliflozin89$100,048
MounjaroTirzepatide76$72,564
OzempicSemaglutide75$67,566
FarxigaDapagliflozin Propanediol69$63,392
TrulicityDulaglutide35$47,587
RybelsusSemaglutide27$38,068
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$24,593
GlyxambiEmpagliflozin/Linagliptin18$23,342
Synjardy XrEmpagliflozin/Metformin Hcl13$21,034
Tresiba Flextouch U-200Insulin Degludec21$17,436
JanuviaSitagliptin Phosphate17$14,259
XareltoRivaroxaban18$14,100
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog23$13,649
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$9,458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi, Synjardy Xr, Synjardy$222$151,342132 claims
Lilly USA, LLCMounjaro, Trulicity$904$120,151111 claims
PfizerEliquis$685$114,774104 claims
Novo NordiskOzempic, Rybelsus$1,305$105,634102 claims
AstraZenecaFarxiga$864$63,39269 claims
MerckJanuvia$125$14,25917 claims
Johnson & JohnsonXarelto$30$14,10018 claims
GSKTrelegy Ellipta$404$9,45818 claims
AbbVieSynthroid$846$2,34834 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in West Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →